-
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by Brokerages
Source: Buzz FX / 09 Feb 2025 00:26:09 America/Chicago
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat February 9, 2025 Share Link copied to clipboard. Shares of Soleno Therapeutics, Inc. ( NASDAQ:SLNO - Get Free Report ) have been giv
Read more...